Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Molecular Pathways Responsible for Adaptive Resistance to Single-Checkpoint Inhibition May Reveal Biomarkers and Immunotherapy Targets in Multiple Myeloma Patients

Barbara Castella, PhD, Myriam Foglietta, MD, Chiara Riganti, PhD, Ezio Tripoli, PharmD, Mario Boccadoro, Massimo Massaia, MD

Blood (2017) 130 (Supplement 1): 1798.

https://doi.org/10.1182/blood.V130.Suppl_1.1798.1798

Published: 2017

Journal Articles

ATP-Binding-Cassette A1 Regulates Extracellular Isopentenyl Pyrophosphate Release and Vγ9Vδ2 T-Cell Activation By Dendritic Cells

Patrizia Sciancalepore, MD, Barbara Castella, PhD, Chiara Riganti, MD, Myriam Foglietta, MD, Joanna Kopecka, PhD, Francesco Novelli, Giorgia Mandili, Ezio Tripoli, PharmD, Nico Mitro, Donatella Caruso, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2016) 128 (22): 3709.

https://doi.org/10.1182/blood.V128.22.3709.3709

Published: 2016

Journal Articles

Immune Checkpoint Blockade Combinations As Promising Strategy for Cancer Immunotherapy in Multiple Myeloma Patients

Barbara Castella, PhD, Myriam Foglietta, MD, Patrizia Sciancalepore, MD, Ezio Tripoli, PharmD, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2016) 128 (22): 2059.

https://doi.org/10.1182/blood.V128.22.2059.2059

Published: 2016

Journal Articles

CD38 and Antibody Therapy: What Can Basic Science Add?

Fabio Malavasi, MD, Antonella Chillemi, PhD, Barbara Castella, PhD, Ilaria Schiavoni, PhD, Danny Incarnato, PhD, Stefania Oliva, MD, Alberto L Horenstein, PhD

Blood (2016) 128 (22): SCI-36.

https://doi.org/10.1182/blood.V128.22.SCI-36.SCI-36

Published: 2016

Journal Articles

The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells

Candida Vitale, MD, Valentina Griggio, MS, Chiara Riganti, MD, Ivana Campia, PhD, Marta Robino, MD, Micol Rigoni, PhD, Patrizia Sciancalepore, MD, Myriam Foglietta, MD PhD, Barbara Castella, PhD, Mario Boccadoro, MD, Massimo Massaia, Marta Coscia, MD PhD

Blood (2014) 124 (21): 833.

https://doi.org/10.1182/blood.V124.21.833.833

Published: 2014

Journal Articles

Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA)

Marta Coscia, MD, PhD, Valentina Griggio, Michela Capello, PhD, Candida Vitale, MD, Federica Linty, PhD, Paola Cappello, PhD, Giorgia Mandili, PhD, Barbara Castella, PhD, Myriam Foglietta, MD, Micol Rigoni, PhD, Patrizia Sciancalepore, MD, Marta Robino, Marina Ruggeri, PhD, Daniela Drandi, PhD, Paola Omedè, PhD, Marco Ladetto, MD, Francesco Novelli, MD, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2012) 120 (21): 3878.

https://doi.org/10.1182/blood.V120.21.3878.3878

Published: 2012

Journal Articles

The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL)

Marta Coscia, MD, PhD, Micol Rigoni, PhD, Chiara Riganti, MD, Candida Vitale, MD, Ivana Campia, PhD, Valentina Griggio, PhD, Myriam Foglietta, MD, Barbara Castella, PhD, Patrizia Sciancalepore, MD, Maria Elisa Canepari, MD, Marta Robino, Daniela Drandi, PhD, Marco Ladetto, MD, Amalia Bosia, MD, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2012) 120 (21): 3881.

https://doi.org/10.1182/blood.V120.21.3881.3881

Published: 2012

Journal Articles

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells

Marta Coscia, Candida Vitale, Silvia Peola, Myriam Foglietta, Micol Rigoni, Valentina Griggio, Barbara Castella, Daniela Angelini, Sabina Chiaretti, Chiara Riganti, Anna Guarini, Daniela Drandi, Marco Ladetto, Amalia Bosia, Robin Foà, Luca Battistini, Mario Boccadoro, Jean-Jacques Fournié, Massimo Massaia

Blood (2012) 120 (16): 3271–3279.

https://doi.org/10.1182/blood-2012-03-417519

Published: 2012

Includes: Supplemental data

Journal Articles

The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells

Marta Coscia, MD, PhD, Micol Rigoni, PhD, Chiara Riganti, MD, Ivana Campia, PhD, Candida Vitale, MD, Valentina Griggio, PhD, Silvia Peola, PhD, Barbara Castella, PhD, Patrizia Sciancalepore, MD, Daniela Drandi, PhD, Marco Ladetto, MD, Amalia Bosia, MD, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2011) 118 (21): 735.

https://doi.org/10.1182/blood.V118.21.735.735

Published: 2011

Journal Articles

Identification by Serological Proteome Analysis (SERPA) of Tumor-Associated Antigens Eliciting Antibody Responses In Chronic Lymphocytic Leukemia (CLL)

Marta Coscia, MD, PhD, Michela Capello, PhD, Valentina Griggio, PhD, Federica Linty, PhD, Candida Vitale, MD, Silvia Peola, PhD, Barbara Castella, PhD, Micol Rigoni, PhD, Daniela Drandi, PhD, Marina Ruggeri, PhD, Paola Omedè, PhD, Marco Ladetto, MD, Franco Novelli, MD, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2010) 116 (21): 917.

https://doi.org/10.1182/blood.V116.21.917.917

Published: 2010

Journal Articles

IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals

Marta Coscia, MD, PhD, Francesca Pantaleoni, PhD, Chiara Riganti, MD, Candida Vitale, MD, Micol Rigoni, PhD, Silvia Peola, PhD, Daniela Drandi, PhD, Barbara Castella, PhD, Marina Ruggeri, PhD, Paola Omedè, MD, Marco Ladetto, MD, Amalia Bosia, MD, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2010) 116 (21): 2431.

https://doi.org/10.1182/blood.V116.21.2431.2431

Published: 2010

Journal Articles

Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid

Francesca Fiore, Barbara Castella, Barbara Nuschak, Raffaello Bertieri, Sara Mariani, Benedetto Bruno, Francesca Pantaleoni, Myriam Foglietta, Mario Boccadoro, Massimo Massaia

Blood (2007) 110 (3): 921–927.

https://doi.org/10.1182/blood-2006-09-044321

Published: 2007

Includes: Supplemental data

Journal Articles

Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells.

Francesca Fiore, MD, Barbara Castella, Barbara Nuschak, Raffaello Bertieri, MD, Sara Mariani, Serena Zappia, Marta Coscia, MD, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2006) 108 (11): 3893.

https://doi.org/10.1182/blood.V108.11.3893.3893

Published: 2006

Journal Articles

Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions.

Myriam Foglietta, MD, Sara Mariani, Barbara Castella, Marta Coscia, MD, Laura Godio, MD, Serena Zappia, Mario Boccadoro, MD, Massimo Massaia, MD

Blood (2006) 108 (11): 658.

https://doi.org/10.1182/blood.V108.11.658.658

Published: 2006

NARROW

Molecular Pathways Responsible for Adaptive Resistance to Single-Checkpoint Inhibition May Reveal Biomarkers and Immunotherapy Targets in Multiple Myeloma Patients

ATP-Binding-Cassette A1 Regulates Extracellular Isopentenyl Pyrophosphate Release and Vγ9Vδ2 T-Cell Activation By Dendritic Cells

Immune Checkpoint Blockade Combinations As Promising Strategy for Cancer Immunotherapy in Multiple Myeloma Patients

CD38 and Antibody Therapy: What Can Basic Science Add?

The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells

Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA)

The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL)

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells

The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells

Identification by Serological Proteome Analysis (SERPA) of Tumor-Associated Antigens Eliciting Antibody Responses In Chronic Lymphocytic Leukemia (CLL)

IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals

Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid

Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells.

Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only